Variables | HDL-c | ||
---|---|---|---|
Adequate n = 42 | Borderline-low n = 20 | P | |
Pubescent, N (%) | 33 (78.6) | 9 (45) | 0.559 |
BMI | 17.9 (17–21.2) | 18.6 (16.1–20.3) | 0.952 |
Z-Score BMI/age > 1 | 7 (16.7) | 6 (30) | 0.228 |
CHAQ | 0.27 (0.1–0.6) | 0.55 (0.3–1.03) | 0.292 |
> 0, N (%) | 10 (23.8) | 7 (35) | 0.356 |
Disease activity | |||
Active, N (%) | 16 (38.1) | 5 (25) | 0.308 |
us-CRP | 1.2 (0.5–4.9) | 2.8 (0.9–15) | 0.312 |
≥ 3 | 14 (33.3) | 10 (50.0) | 0.208 |
ESR | 6.5 (5.0–30.0) | 19.5 (6.0–32.0) | 0.191 |
≥ 20 | 15 (35.7) | 10 (50.0) | 0.407 |
HDL-c | 50.0 (45.0–59.0) | 46.0 (42.0–49.0) | 0.271 |
Borderline/Low N (%) | 14 (28.6) | 6 (46.2) | 0.351 |
LDL-c | 86.4 (72.2–103.0) | 84.4 (71.2–99.4) | 0.646 |
Borderline/High | 8 (19.0) | 4 (20.0) | 1.000 |
Triglycerides | 66.5 (51.0–85.0) | 62.0 (51.5–88.5) | 0.821 |
Borderline/High | 12 (28.6) | 5 (25.0) | 1.000 |
Apo A-1 | 118.0 (108.0–137.0) | 100.0 (92.0–106.5) | < 0.001 |
Borderline/Low | 23 (54.8) | 19 (95.0) | 0.001 |
Apo B | 72.5 (58.0–84.0) | 68.0 (58.5–83.5) | 0.821 |
Borderline/Low | 5 (11.9) | 4 (20.0) | 0.453 |
NHDL-c | 99.0 (87.0–124.0) | 96.5 (82.5–119.5) | 0.474 |
Borderline/Low | 12 (28.6) | 5 (25.0) | 1.000 |